1-6 of 6
Erlend B. Smeland, MD,PhD
Close
Sort by
Journal Articles

Deep Profiling of Genetic Aberrations and Clonal Evolution in Follicular Lymphoma

Baoyan Bai, PhD, Daniel Vodák, BS, Sigve Nakken, PhD, Jillian F. Wise, PhD, Yngvild Nuvin Blaker, MD PhD, Ole Christian Lingjærde, PhD, Marianne Brodtkorb, MD PhD, Vera Hilden, Gunhild Trøen, Suzanne Lorenz, PhD, Michael S. Lawrence, PhD, Ola Myklebost, PhD, Leonardo Meza-Zepeda, PhD, Klaus Beiske, MD PhD, Eivind Hovig, PhD, Erlend B. Smeland, MD PhD, Harald Holte, MD PhD, June Helen Myklebust, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 20.
https://doi.org/10.1182/blood-2019-128403
Published: 2019
Journal Articles

Mutational Dynamics and Evolutionary Divergence in DLBCL: A Call for Relapse Sampling

Jillian F. Wise, PhD, Sigve Nakken, PhD, Chloé B Steen, PhD, Daniel Vodák, BS, Gunhild Trøen, Bjarne Johannessen, PhD, Ole Christian Lingjærde, PhD, Vera Hilden, Yngvild Nuvin Blaker, MD PhD, Baoyan Bai, PhD, Lars B. Aasheim, Annika Pasanen, MD PhD, Suzanne Lorenz, PhD, Anita Sveen, PhD, Ragnhild Lothe, PhD, Ola Myklebost, PhD, Sirpa Leppa, MD Prof, Leonardo Meza-Zepeda, PhD, Klaus Beiske, MD PhD, Michael S. Lawrence, PhD, Eivind Hovig, PhD, June Helen Myklebust, PhD, Erlend B. Smeland, MD PhD, Harald Holte, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1497.
https://doi.org/10.1182/blood-2019-131072
Published: 2019
Journal Articles

The DLBCL90 Double-Hit Gene Expression Signature Is Not Associated with Inferior Survival in Young High-Risk Patients with Diffuse Large B-Cell Lymphoma Treated with Dose-Intensive Immunochemotherapy

Kathrine T. Isaksen, MD, Klaus Beiske, MD PhD, Erlend B. Smeland, MD PhD, Judit Jørgensen, MD PhD, Marianne Brodtkorb, MD PhD, June Helen Myklebust, PhD, Mats Jerkeman, MD Professor, Leo Meriranta, MD, Marja-Liisa Karjalainen-Lindsberg, MD PhD, Sirpa Leppa, MD PhD, David W. Scott, MBChB, PhD, Harald Holte, MD PhD, Yngvild Nuvin Blaker, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1485.
https://doi.org/10.1182/blood-2019-121467
Published: 2019
Journal Articles

B Cell Lymphomas Escape Bone Morphogenetic Protein (BMP) Induced Growth Inhibition: Downregulation of BMP Receptors and Upregulation of Inhibitory Smads.

Kanutte Huse, M.S, Maren Bakkebo, M.S, Morten Oksvold, PhD, Erlend B. Smeland, MD, PhD, June H. Myklebust, PhD
Journal: Blood
Blood (2007) 110 (11): 2605.
https://doi.org/10.1182/blood.V110.11.2605.2605
Published: 2007
Journal Articles

Characterization of Early Human B Cell Development by Gene Expression Profiling.

Marit E. Hystad, PhD, Trond H. Bo, PhD, Edith Rian, PhD, June H. Myklebust, PhD, Einar Sivertsen, MD, Lise Forfang, Michael Chiorazzi, Andreas Rosenwald, MD, Inge Jonassen, PhD, Louis M. Staudt, MD,PhD, Erlend B. Smeland, MD,PhD
Journal: Blood
Blood (2006) 108 (11): 1352.
https://doi.org/10.1182/blood.V108.11.1352.1352
Published: 2006
Journal Articles

B Cell Lymphomas Are Resistant towards Bone Morphogenetic Protein (BMP) Induced Growth Inhibition.

Kanutte Huse, MS, Marianne B. Eide, MD, Christian Kersten, MD, Erlend B. Smeland, MD, PhD, June H. Myklebust, PhD
Journal: Blood
Blood (2006) 108 (11): 2381.
https://doi.org/10.1182/blood.V108.11.2381.2381
Published: 2006